Heat Shock Proteins in Experimental Glaucoma

Cynthia Grosskreutz, MD, PhD
Massachusetts Eye and Ear Infirmary (Boston, MA)
Year Awarded:
2005
Grant Duration:
April 1, 2005 to March 31, 2007
Disease:
Glaucoma
Award Amount:
$90,000
Grant Reference ID:
G2005026
Award Type:
Standard
Award Region:
US Northeastern

Heat Shock Proteins in Experimental Glaucoma

Details

Heat shock proteins (HSP) are a group of highly conserved proteins that act in a coordinated response to environmental and physiological stress. It has been recently observed that one member of this protein family, HSP27, is elevated in certain genetic models of glaucoma. Dr. Grosskreutz hopes to discover whether experimentally increasing HSP27 levels in the eye will prevent neuronal death in the retina in glaucoma. She will apply this gene therapy to increase and decrease HSP27 levels in the retina and record changes. Together, these results will provide important new information regarding the role of heat shock proteins in retinal ganglion cell death in glaucoma, and provide clues to new neuroprotective treatment approaches for this blinding disease.
Don't miss out.
Receive research updates, inspiring stories, and expert advice
Please enter your first name.
Please enter your last name.
Keep me informed about: *
Please select at least one.
You must select at least one disease category.